In the other study, MEHP has been shown to stimulate steroidogenesis, decrease progesterone production, and aromatase levels in rat GCs, leading to hyperandrogenism, a cardinal feature of PCOS [227]. This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.